Investment
Features
FeesSafety
Academy
More
Pluang+

Bull Bitcoin users still can't convert L-BTC to BTC after Liquid Network hack; swap may resume in 30 days.

Market News
23 Sep 2026
Tokenpost
View Source
Bearish
Bull Bitcoin users still can't convert L-BTC to BTC after Liquid Network hack; swap may resume in 30 days.

Bull Bitcoin customers remain unable to convert Liquid Bitcoin (L-BTC) into Bitcoin (BTC) due to a security exploit on the Liquid Network on September 6. The hack created about 4,000 unbacked L-BTC, causing the peg-out system to be suspended. Although Liquid resumed normal network transactions on September 10, peg-outs remain paused as the network works on restoring full BTC backing, software updates, and security reviews. Bull Bitcoin estimates swap services could resume within 30 days but offers no guarantee, leaving users waiting to convert their L-BTC back to BTC.

Bull Bitcoin withdrawal delays provide context for cryptocurrency market trends. For readers following crypto, here is Pluang's market snapshot as of Sep 23, 2026 23:05 WIB: out of 50 major cryptocurrencies, 8 rose and 41 fell. Notable movers include AVAX at Rp181.096 with a -9.12% change, DOGE at Rp1.646 down -8.15%, and EOS at Rp12.649 up 8.13%.

More News

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...

Analyst Insights
Bullish
2 hours ago
BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...

Analyst Insights
Bearish
3 hours ago
Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...

Analyst Insights
Bullish
3 hours ago
Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...

Analyst Insights
Bullish
3 hours ago
Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App